Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
r executive positions with Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head of Global Drug Development with Hoffman-La Roche in Basel, Switzerland and previously was with Syntex Corporation for over 10 years in various senior positions in drug development. Dr. Dow holds a B.Sc. in
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
2 mentions1 same-page
Page ?Same page
r executive positions with Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head of Global Drug Development with Hoffman-La Roche in Basel, Switzerland and previously was with Syntex Corporation for over 10 years in various senior positions in drug development. Dr. Dow holds a B.Sc. in
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
2 mentions1 same-page
Page ?Same page
r executive positions with Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head of Global Drug Development with Hoffman-La Roche in Basel, Switzerland and previously was with Syntex Corporation for over 10 years in various senior positions in drug development. Dr. Dow holds a B.Sc. in
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
Sponsored
Mutual Connections (64)
Entities connected to both Basel and Biolitec Pharma Ltd.
Alan Dershowitz
PERSON14 w/ Basel·3 w/ Biolitec
Novartis AG
ORGANIZATION7 w/ Basel·3 w/ Biolitec
the Board of Directors
ORGANIZATION6 w/ Basel·3 w/ Biolitec
Merck
ORGANIZATION6 w/ Basel·3 w/ Biolitec
Kansas
LOCATION5 w/ Basel·3 w/ Biolitec
Merck & Co.
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Target
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Elkins
PERSON3 w/ Basel·3 w/ Biolitec
Silicon Valley
LOCATION3 w/ Basel·3 w/ Biolitec
Investigatorship
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Biosecurity
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Strategic Product Development
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Cell Genesys'
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Quantanova
ORGANIZATION3 w/ Basel·3 w/ Biolitec
the University of St. Andrews
ORGANIZATION3 w/ Basel·3 w/ Biolitec
the Faculty of Pharmaceutical Physicians
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Cobalt Technologies, Inc.
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Xenogen Corporation
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Microbiology and Engineering
ORGANIZATION3 w/ Basel·3 w/ Biolitec
Medarex, Inc.
ORGANIZATION3 w/ Basel·3 w/ Biolitec